Here's why #rstats users should be happy about Rstudio changing its name to Posit. 🧵 1⃣ It's easier to sell Posit products to your organization. Even though Rstudio Teams is a really good development ecosystem for Python work, it's very hard to express that because Rstudio's brand association is mostly R.

I think Dr. Bogoch is making two mistakes here:

1. Picking a bad prior
2. Using inconsistent evidentiary standards

https://twitter.com/BogochIsaac/status/1322923258266746881

1) Researchers often pick a general prior for vitamin D based on all vitamin D trials. There are many failed vitamin D trials for things like cancer, diabetes, or all cause mortality.

This is an open label study of 584 Brazillian Covid patients. Study participants took either hydroxychloroquine, nitazoxanide or ivermectin and none (!!) of them went to the hospital or died.

researchsquare.com/article/rs-981… Now there's certainly something wrong with this study. 16% of Brazillian Covid patients go to the hospital so the odds of finding one drug that eliminates hospitalization are small; the odds of finding three in one trial are basically zero.